Cardiac and genetic predictors of cardiovascular risk in patients with myelodysplastic syndromes.
作者信息
Chen Evan C, Werner Lillian, Hobbs Gabriela S, Narayan Rupa, Amrein Philip C, Fathi Amir T, Brunner Andrew M
机构信息
Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
Biostatistics Core, Dana-Farber Cancer Institute, Boston, MA, USA.
出版信息
Leuk Lymphoma. 2019 Dec;60(12):3058-3062. doi: 10.1080/10428194.2019.1617863. Epub 2019 May 23.
Abstract
摘要
相似文献
1
Cardiac and genetic predictors of cardiovascular risk in patients with myelodysplastic syndromes.骨髓增生异常综合征患者心血管风险的心脏和遗传预测因素
Leuk Lymphoma. 2019 Dec;60(12):3058-3062. doi: 10.1080/10428194.2019.1617863. Epub 2019 May 23.
2
High resolution single nucleotide polymorphism array reveals cryptic indicating information about myelodysplastic syndrome-related myeloid malignancies.高分辨率单核苷酸多态性阵列揭示了与骨髓增生异常综合征相关的髓系恶性肿瘤的隐匿指示信息。
Leuk Lymphoma. 2015;56(10):2969-72. doi: 10.3109/10428194.2015.1020803. Epub 2015 Jun 19.
3
Familial Monosomy 7 Syndrome Associated with Myelodysplasia.与骨髓发育异常相关的家族性单体7综合征
Indian J Pediatr. 2019 Nov;86(11):1059. doi: 10.1007/s12098-019-02990-9. Epub 2019 Jun 17.
4
Single-molecule DNA sequencing of acute myeloid leukemia and myelodysplastic syndromes with multiple alterations.伴有多种改变的急性髓系白血病和骨髓增生异常综合征的单分子DNA测序
Haematologica. 2018 Jan;103(1):e13-e16. doi: 10.3324/haematol.2017.176719. Epub 2017 Oct 27.
5
[New insight into myelodysplastic syndromes and related myeloid disorders].[骨髓增生异常综合征及相关髓系疾病的新见解]
Rinsho Ketsueki. 2013 Jun;54(6):533-7.
6
Gene expression signatures of pediatric myelodysplastic syndromes are associated with risk of evolution into acute myeloid leukemia.小儿骨髓增生异常综合征的基因表达特征与演变为急性髓系白血病的风险相关。
Leukemia. 2012 Jul;26(7):1717-9. doi: 10.1038/leu.2012.35. Epub 2012 Feb 7.
7
GATA2 and secondary mutations in familial myelodysplastic syndromes and pediatric myeloid malignancies.GATA2与家族性骨髓增生异常综合征及儿童髓系恶性肿瘤中的继发突变
Haematologica. 2015 Oct;100(10):e398-401. doi: 10.3324/haematol.2015.127092. Epub 2015 May 28.
8
Presence of new mutations in the TP53 gene in patients with low-risk myelodysplastic syndrome: two case reports.低危骨髓增生异常综合征患者TP53基因新突变的存在：两例报告
J Med Case Rep. 2017 May 21;11(1):143. doi: 10.1186/s13256-017-1301-8.
9
The lack of association between JAK2 V617F mutation and myelodysplastic syndrome with or without myelofibrosis.JAK2 V617F突变与伴有或不伴有骨髓纤维化的骨髓增生异常综合征之间缺乏关联。
Leukemia. 2006 Jun;20(6):1165. doi: 10.1038/sj.leu.2404196.
10
A case of Behcet's disease associated with myelodysplastic syndrome involving trisomy 8 and a gain-of-function mutation in SHP-2.1例白塞病合并骨髓增生异常综合征，涉及8号染色体三体及SHP-2功能获得性突变。
Rheumatology (Oxford). 2011 Jul;50(7):1342-4. doi: 10.1093/rheumatology/ker137. Epub 2011 Apr 10.
引用本文的文献
1
Role of Population Based Studies in Advancing our Knowledge of Myelodysplastic Syndromes.基于人群的研究在增进我们对骨髓增生异常综合征认识方面的作用。
Curr Hematol Malig Rep. 2025 Jan 17;20(1):6. doi: 10.1007/s11899-025-00750-5.
2
Genomic Aging, Clonal Hematopoiesis, and Cardiovascular Disease.基因组衰老、克隆性造血与心血管疾病
Arterioscler Thromb Vasc Biol. 2023 Jan;43(1):3-14. doi: 10.1161/ATVBAHA.122.318181. Epub 2022 Nov 10.
3
Risk factors for cardiovascular disease mortality in patients with myelodysplastic syndromes: A nationwide, registry-based cohort study.骨髓增生异常综合征患者心血管疾病死亡的危险因素：一项基于全国登记处的队列研究。
EJHaem. 2020 Jul 1;1(1):255-261. doi: 10.1002/jha2.30. eCollection 2020 Jul.
4
Predictors of vascular disease in myelodysplastic syndromes.骨髓增生异常综合征中血管疾病的预测因素。
EJHaem. 2020 Sep 28;1(2):467-472. doi: 10.1002/jha2.101. eCollection 2020 Nov.
本文引用的文献
1
Clonal hematopoiesis of indeterminate potential-associated mutations and risk of comorbidities in patients with myelodysplastic syndrome.克隆性造血不定潜能相关突变与骨髓增生异常综合征患者合并症风险。
Cancer. 2019 Jul 1;125(13):2233-2241. doi: 10.1002/cncr.32056. Epub 2019 Mar 12.
2
Risk and timing of cardiovascular death among patients with myelodysplastic syndromes.骨髓增生异常综合征患者心血管死亡的风险及时间
Blood Adv. 2017 Oct 18;1(23):2032-2040. doi: 10.1182/bloodadvances.2017010165. eCollection 2017 Oct 24.
3
Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease.克隆性造血与动脉粥样硬化性心血管疾病风险
N Engl J Med. 2017 Jul 13;377(2):111-121. doi: 10.1056/NEJMoa1701719. Epub 2017 Jun 21.
4
Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice.与TET2缺陷相关的克隆性造血加速小鼠动脉粥样硬化发展。
Science. 2017 Feb 24;355(6327):842-847. doi: 10.1126/science.aag1381. Epub 2017 Jan 19.
5
Validation and Implementation of a Custom Next-Generation Sequencing Clinical Assay for Hematologic Malignancies.一种用于血液系统恶性肿瘤的定制下一代测序临床检测方法的验证与实施
J Mol Diagn. 2016 Jul;18(4):507-15. doi: 10.1016/j.jmoldx.2016.02.003.
6
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.2016 年版世界卫生组织髓系肿瘤和急性白血病分类。
Blood. 2016 May 19;127(20):2391-405. doi: 10.1182/blood-2016-03-643544. Epub 2016 Apr 11.
7
Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence.从血液DNA序列推断克隆性造血与血癌风险。
N Engl J Med. 2014 Dec 25;371(26):2477-87. doi: 10.1056/NEJMoa1409405. Epub 2014 Nov 26.
8
Age-related clonal hematopoiesis associated with adverse outcomes.与不良预后相关的年龄相关性克隆性造血。
N Engl J Med. 2014 Dec 25;371(26):2488-98. doi: 10.1056/NEJMoa1408617. Epub 2014 Nov 26.
9
Anchored multiplex PCR for targeted next-generation sequencing.靶向下一代测序的锚定多重 PCR。
Nat Med. 2014 Dec;20(12):1479-84. doi: 10.1038/nm.3729. Epub 2014 Nov 10.
10
Validation of the atherosclerotic cardiovascular disease Pooled Cohort risk equations.验证动脉粥样硬化性心血管疾病的汇总队列风险方程。
JAMA. 2014 Apr 9;311(14):1406-15. doi: 10.1001/jama.2014.2630.
Zotero 插件